and REAP-seq (RNA expression and protein sequencing assay) to investigate the relationship between RNA transcripts and proteins, and identify new cell types and cell states associated with disease.

In fact, when we applied for accreditation from the CAP (College of American Pathologists), we worked with them to create the first whole-transcriptome sequencing activity as a reportable assay." ...

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger ...

The Genomics Core now has an Illumina NextSeq500 Next Generation Sequencing (NGS) instrument ... and targeted and whole genome assays. The Genomic Core Laboratory has the capacity to provide a wide ...

The core runs the NextSeq500 and two MiSeq sequencers. Cost per samples varies depending on the assay, platform and sequencing length, as mentioned above. Many different samples can be multiplexed and ...

Adoption of NGS assays in preference to qPCR could happen faster in clinical microbiology, where the pathogen sequencing platforms are almost comparable now in terms of speed and cost. New NGS ...

One of the major challenges that scientists face while using DNA barcoding techniques for high-throughput assays is labeling bias, which could lead to some sequencing features being over- or ...

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...

DNA sequencing has been the gold-standard genotyping ... genotypic and phenotypic testing on a single patient sample. This assay, called PhenoSense GT, combines PhenoSense and GeneSeq testing ...